1. Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer
    Silvia Cruz-Gil et al, 2020, Cancers CrossRef
  2. Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis
    Zehua Zhang et al, 2021, Human Cell CrossRef
  3. Cisplatin and Exogenous Hydrogen Sulfide Inhibit the Progression of Osteosarcoma via EGFR/P13K/Akt Signaling Pathway
    Hao Wu et al, 2022, Journal of Biomaterials and Tissue Engineering CrossRef
  4. Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance
    Peng He et al, 2023, Journal of Nanobiotechnology CrossRef
  5. Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment
    Yufeng Liu et al, 2020, Cell Biochemistry and Function CrossRef
  6. Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases
    Jan Korbecki et al, 2024, Cancers CrossRef
  7. MicroRNA‑504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
    Xin Chen et al, 2018, Oncology Letters CrossRef
  8. Integrative Network Analysis of Differentially Methylated and Expressed Genes for Biomarker Identification in Leukemia
    Robersy Sanchez et al, 2020, Scientific Reports CrossRef
  9. Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells
    Amirhosein Maharati et al, 2024, Heliyon CrossRef
  10. The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review
    Victoria L. Tippett et al, 2023, Oncogene CrossRef
  11. Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia
    Eleni-Anastasia Triantafyllou et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef

  12. Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis


    Ling Liu et al, 2020, OncoTargets and Therapy CrossRef
  13. Regulation of Molecular Targets in Osteosarcoma Treatment
    Betul Celik et al, 2022, International Journal of Molecular Sciences CrossRef
  14. Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2
    Zhengxiang Huang et al, 2021, Journal of Chemotherapy CrossRef
  15. Long noncoding RNA OIP5‐AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR‐340‐5p
    Lei Song et al, 2019, Journal of Cellular Biochemistry CrossRef
  16. Lipid Metabolism in Cancer: The Role of Acylglycerolphosphate Acyltransferases (AGPATs)
    Angeliki Karagiota et al, 2022, Cancers CrossRef